Results 161 to 170 of about 28,421 (276)

Measles: What we have learned from non-human primate models [PDF]

, 2018
Studies in non-human primates (NHPs) have been crucial for our understanding of measles as a high impact viral disease of humans. Over a century ago, inoculations of NHPs with filtered secretions from measles patients first identified a virus as the ...
Swart, R.L. (Rik) de
core   +1 more source

Ascites of patients with solid tumors shows distinct inflammatory patterns

Cancer Communications, Volume 45, Issue 8, Page 936-940, August 2025.
Julia M. Berger, Martin Korpan, Carina Zierfuss, Katharina Syböck, Erwin Tomasich, Andreas Kienzle, Maria Koenig, Markus Kleinberger, Lynn Gottmann, Birgit Fendl, Cihan Ay, Johannes Pammer, Catharina Müller, Rudolf Oehler, Lorenz Balcar, Thomas Reiberger, Elisabeth S. Bergen, Barbara Niederdorfer, Matthias Preusser, Anna S. Berghoff   +19 more
wiley   +1 more source

Gene therapy of liver cancer [PDF]

, 2006
The application of gene transfer technologies to the treatment of cancer has led to the development of new experimental approaches like gene directed enzyme/pro-drug therapy (GDEPT), inhibition of oncogenes and restoration of tumor-suppressor genes.
Hernandez-Alcoceba, R. (Rubén), Prieto, J. (Jesús), Sangro, B. (Bruno)   +2 more
core   +1 more source

Supplementary Table S2 from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

, 2023
Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy   +10 more
openalex   +1 more source

Oncolytic Replication of E1b-Deleted Adenoviruses

Viruses, 2015
Various viruses have been studied and developed for oncolytic virotherapies. In virotherapy, a relatively small amount of viruses used in an intratumoral injection preferentially replicate in and lyse cancer cells, leading to the release of amplified ...
Pei-Hsin Cheng, Stephen L. Wechman, Kelly M. McMasters, Heshan Sam Zhou   +3 more
doaj   +1 more source

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9 [PDF]

, 2019
Hans‐Georg Wirsching, Sonali Arora, Huajia Zhang, Frank Szulzewsky, Patrick J. Cimino, Christophe Quéva, A. McGarry Houghton, Joseph C. Glorioso, Michael Weller, Eric C. Holland   +9 more
openalex   +1 more source

Oncolytic virotherapy as a personalized cancer vaccine [PDF]

, 2008
Qi‐Xiang Li, Guohong Liu, Flossie Wong‐Staal   +2 more
openalex   +1 more source

Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy [PDF]

, 2022
Boaz Wong, Anabel Bergeron, Nouf Alluqmani, Glib Maznyi, Andrew Chen, Rozanne Arulanandam, Jean‐Simon Diallo   +6 more
openalex   +1 more source

Analisa Kestabilan Model Matematika untuk Penyembuhan Kanker Menggunakan Oncolytic Virotherapy [PDF]

, 2016
. Oncolytic virotherapy is one type of cancer treatment using oncolytic virus. In this paper, we will present a mathematical model for treatment of cancer using oncolytic virotherapy with the burst size of a virus (the number of new viruses released ...
Via Novellina, Via Novellina
core  

Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy [PDF]

, 2010
Paul T. Sobol, Jeanette E. Boudreau, Kyle B. Stephenson, Yonghong Wan, Brian D. Lichty, Karen Mossman   +5 more
openalex   +1 more source